Trim32 and spinal injury

doi:10.3877/cma.j.issn.2095-9141.2015.05.010

Abstract

Abstract:

Trim32 is a transcription factor, it can promote neural differentiation, restrain neural proliferation and neural apoptosis. Especially it can regulate proliferation and differentiation of neural stem cell, it play an important role in nervous system. So we expect that Trim32 can be useful in the recover of spinal cord injury, this review summarized the spinal cord injury and the role of Trim32 play in the spinal cord injury.

Key words: Spinal cord injury, Mice, Trim32

Qiang Fu, Ruxiang Xu. Trim32 and spinal injury[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2015, 01(05): 37-40.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsjcswkdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9141.2015.05.010

https://zhsjcswkdzzz.cma-cmc.com.cn/EN/Y2015/V01/I05/37

References 45

[1]	Nicaise C, Mitrecic D, Falnikar A, et al. Transplantation of stem cell-derivedastrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury[J]. World J Stem Cells, 2015, 7(2): 380-398.
[2]	Kaya R A, Çavusoglu H, Tanlk C, et al. Spinal cord compression caused by a brown tumor at the cervicothoracic junction[J]. Spine J, 2007, 7(6): 728-732.
[3]	Chen H Y, Boore J R P. Living with a spinal cord injury: a grounded theory approach[J]. J ClinNurs, 2008, 17(5A): 116-24.
[4]	Lan C, Lai JS, Chang KH, et al. Traumatic spinal cord injuries in the rural region of Taiwan: an epidemiological study in Hualien county, 1986-1990[J]. Paraplegia, 1993, 31(6): 398-403.
[5]	Chiu WT, Lin HC, Lam C, et al. Review paper: epidemiology of traumatic spinal cord injury: comparisons between developed and developing countries[J]. Asia Pac J Public Health, 2010, 22(1): 9-18.
[6]	Stevens R D, Bhardwaj A, Kirsch J R, et al. Critical care and perioperative management in traumatic spinal cord injury[J]. J NeurosurgAnesthesiol, 2003, 15(3): 215-229.
[7]	Yang NP, Deng CY, Lee YH, et al. The incidence and characterisation of hospitalised acute spinal trauma in Taiwan--a population-based study.[J]. Injury, 2008, 39(4): 443-450.
[8]	Chen HY, Chen SS, Chiu WT, et al. A nationwide epidemiological study of spinal cord injury in geriatric patients in Taiwan[J]. Neuroepidemiology, 1997, 16(5): 241-247.
[9]	Frankel HL, Coll JR, Charlifue SW, et al. Long-term survival in spinal cord injury: a fifty year investigation[J]. Spinal Cord, 1998, 36(4): 266-274.
[10]	Amin A, Bernard J, Nadarajah R, et al. Spinal injuries admitted to a specialist centre over a 5-year period: a study to evaluate delayed admission[J]. Spinal Cord, 2005, 43(7): 434-437.
[11]	Christensen MD, Hulsebosch CE. Chronic central pain after spinal cord injury[J]. J Neurotrauma, 1997, 14(8): 517-537.
[12]	Tator CH. Biology of neurological recovery and functional restoration after spinal cord injury[J]. Neurosurgery, 1998, 42(4): 696-707.
[13]	Tator CH. Experimental and clinical studies of the pathophysiology and management of acute spinal cord injury[J]. J Spinal Cord Med, 1996, 19(4): 206-214.
[14]	Carlson GD, Gorden C. Current developments in spinal cord injury research[J]. Spine J, 2002, 2(2): 116-128.
[15]	Tator CH. Update on the pathophysiology and pathology of acute spinal cord injury[J]. Brain Pathol, 1995, 5(4): 407-413.
[16]	Dong H, Fazzaro A, Xiang C, et al. Enhanced oligodendrocyte survival after spinal cord injury in Bax-deficient mice and mice with delayed Wallerian degeneration[J]. J Neurosci, 2003, 23(25): 8682-8691.
[17]	Faulkner J R, Herrmann JE, Woo MJ, et al. Reactive astrocytes protect tissue and preserve function after spinal cord injury[J]. J Neurosci, 2004, 24(9): 2143-2155.
[18]	Ditor DS, Hamilton S, Tarnopolsky MA, et al. Na+, K+-ATPase concentration and fiber type distribution after spinal cord injury[J]. Muscle Nerve, 2004, 29(1): 38-45.
[19]	Kaptanoglu E, Solaroglu I, Okutan O, et al. Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings[J]. Neurosurg Rev, 2004, 27(2): 113-120.
[20]	Guest J, Eleraky MA, Apostolides PJ, et al. Traumatic central cord syndrome: results of surgical management[J]. J Neurosurg, 2002, 97(1): 25-32.
[21]	Management of acute central cervical spinal cord injuries[J]. Neurosurgery, 2002, 50(3): S166-S172.
[22]	Geisler FH, Coleman WP, Grieco G, et al. Recruitment and early treatment in a multicenter study of acute spinal cord injury[J]. Spine, 2001, 26(24S): S58-S67.
[23]	Geisler FH, Coleman WP, Grieco G, et al. The Sygen multicenter acute spinal cord injury study[J]. Spine, 2001, 26(24S): S87-S98.
[24]	Giger RJ, Venkatesh K, Chivatakarn O, et al. Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems[J]. RestorNeurolNeurosci, 2008, 26(2-3): 97-115.
[25]	Di Giovanni S. Molecular targets for axon regeneration: focus on the intrinsic pathways[J]. Expert OpinTher Targets, 2009, 13(12): 1387-1398.
[26]	Yiu G, He Z. Glial inhibition of CNS axon regeneration[J]. Nat Rev Neurosci, 2006, 7(8): 617-627.
[27]	Chiang AP, Beck JS, Yen HJ, et al. Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet–Biedl syndrome gene (BBS11)[J]. Proc Natl AcadSci, 2006, 103(16): 6287-6292.
[28]	Kano S, Miyajima N, Fukuda S, et al. Tripartite motif protein 32 facilitates cell growth and migration via degradation of Abl-interactor 2[J]. Cancer Res, 2008, 68(14): 5572-5580.
[29]	Fridell RA, Harding LS, Bogerd HP, et al. Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins[J]. Virology, 1995, 209(2): 347-357.
[30]	Reymond A, Meroni G, Fantozzi A, et al. The tripartite motif family identifies cell compartments[J]. EMBO J, 2001, 20(9): 2140-2151.
[31]	Kudryashova E, Kudryashov D, Kramerova I, et al. Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinatesactin[J]. J MolBiol, 2005, 354(2): 413-424.
[32]	Kudryashova E, Wu J, Havton LA, et al. Deficiency of the E3 ubiquitin ligase TRIM32 in mice leads to a myopathy with a neurogenic component[J]. Hum Mol Genet, 2009, 18(7): 1353-1367.
[33]	Locke M, Tinsley CL, Benson MA, et al. TRIM32 is an E3 ubiquitin ligase for dysbindin[J]. Hum Mol Genet, 2009, 18(13): 2344-2358.
[34]	Lee CY, Robinson KJ, Doe CQ. Lgl, Pins and aPKC regulate neuroblast self-renewal versus differentiation[J]. Nature, 2006, 439(7076): 594-598.
[35]	Knoblich JA. Mechanisms of asymmetric stem cell division[J]. Cell, 2008, 132(4): 583-597.
[36]	Rolls MM, Albertson R, Shih HP, et al. Drosophila aPKC regulates cell polarity and cell proliferation in neuroblasts and epithelia[J]. J Cell Biol, 2003, 163(5): 1089-1098.
[37]	Betschinger J, Mechtler K, Knoblich JA. Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells[J]. Cell, 2006, 124(6): 1241-1253.
[38]	Treier M, Staszewski LM, Bohmann D. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain[J]. Cell, 1994, 78(5): 787-798.
[39]	Yu F, Yao H, Zhu P, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells[J]. Cell, 2007, 131(6): 1109-1123.
[40]	Peng Y, Laser J, Shi G, et al. Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma[J]. Mol Cancer Res, 2008, 6(4): 663-673.
[41]	Johnson C D, Esquela-Kerscher A, Stefani G, et al. The let-7 microRNA represses cell proliferation pathways in human cells[J]. Cancer Res, 2007, 67(16): 7713-7722.
[42]	Glaser T, Brüstle O. Retinoic acid induction of ES-cell-derived neurons: the radial glia connection[J]. Trends Neurosci, 2005, 28(8): 397-400.
[43]	Weston A D, Blumberg B, Underhill TM. Active repression by unliganded retinoid receptors in development less is sometimes more[J]. J Cell Biol, 2003, 161(2): 223-228.
[44]	Sato T, Okumura F, Kano S, et al. TRIM32 promotes neural differentiation through retinoic acid receptor-mediated transcription[J]. J Cell Sci, 2011, 124(Pt 20): 3492-3502.
[45]	Schwamborn JC, Berezikov E, Knoblich J A. The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors[J]. Cell, 2009, 136(5): 913-925.

Please choose a citation manager

Content to export